Therapeutic effect of massive hepatocellular carcinoma

summary

The yellowing of the skin and eyes of patients with liver cancer is an obvious symptom of liver cancer. Due to gastrointestinal flatulence, large liver tumor, ascites and other causes, the treatment effect of massive liver cancer, the following is an introduction to the symptoms of liver cancer by experts.

Therapeutic effect of massive hepatocellular carcinoma

Treatment 1: targeted therapy is to use an antibody or compound with special affinity for liver cancer as a "carrier", or guide it through physical action, such as magnetism, or guide it through tumor blood vessel specificity, such as Lipiodol, and then combine it with "warheads" (radionuclides, chemotherapeutic drugs, toxin protein, BRM, etc.) with anti-tumor effect, so as to achieve more anti-tumor and less positive damage The purpose of the organization.

Treatment 2: immunotherapy: BCG, Corynebacterium parvum, levamisole, tumor vaccine, embryonic cells, thymosin, transfer factor, immune ribonucleic acid, etc. have been tried in China, but no obvious effect has been achieved.

Treatment 3: anhydrous alcohol injection treatment in recent years, there are many clinical reports of anhydrous alcohol injection under the guidance of B ultrasound in the treatment of liver cancer. This kind of therapy has obvious effect in reducing the focus, controlling and delaying the growth of tumor. Because this therapy does not need special conditions, the operation method is simple, the complications are few, the pain of patients is small, and the cost is low, so it is widely used in clinical practice.

matters needing attention

In clinic, the treatment of advanced liver cancer commonly includes surgery, radiotherapy and chemotherapy, but for patients with advanced liver cancer, the development of the disease and the emergence of complications, the single treatment method has great limitations for the treatment of advanced liver cancer, so it is necessary to formulate the treatment plan of advanced liver cancer combined with the detailed situation of patients, in order to reduce the damage of the disease for patients with advanced liver cancer.